Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Communication | 2 | 2017 | 116 | 0.240 |
Why?
|
| Esophageal Neoplasms | 2 | 2016 | 150 | 0.240 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 258 | 0.230 |
Why?
|
| Esophagus | 2 | 2016 | 303 | 0.220 |
Why?
|
| Phosphofructokinase-1, Type C | 1 | 2021 | 7 | 0.200 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 22 | 0.200 |
Why?
|
| Receptors, CXCR4 | 1 | 2021 | 48 | 0.200 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 20 | 0.180 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2020 | 50 | 0.170 |
Why?
|
| Mitochondrial Membranes | 1 | 2019 | 45 | 0.170 |
Why?
|
| Single-Cell Analysis | 3 | 2017 | 35 | 0.170 |
Why?
|
| Mitochondria | 3 | 2019 | 643 | 0.170 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2019 | 62 | 0.170 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 113 | 0.160 |
Why?
|
| Cell Nucleus | 2 | 2017 | 305 | 0.160 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 148 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 215 | 0.160 |
Why?
|
| Tomography, Optical | 1 | 2017 | 2 | 0.160 |
Why?
|
| Stress, Physiological | 1 | 2019 | 215 | 0.150 |
Why?
|
| Bioreactors | 1 | 2017 | 65 | 0.140 |
Why?
|
| Neoplasms | 2 | 2020 | 1664 | 0.140 |
Why?
|
| Hydroxamic Acids | 1 | 2016 | 84 | 0.130 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 116 | 0.130 |
Why?
|
| Energy Metabolism | 1 | 2017 | 222 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2019 | 617 | 0.130 |
Why?
|
| Mitoxantrone | 1 | 2013 | 7 | 0.120 |
Why?
|
| Eukaryota | 1 | 2013 | 10 | 0.120 |
Why?
|
| Archaea | 1 | 2013 | 7 | 0.120 |
Why?
|
| Seawater | 1 | 2013 | 29 | 0.120 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2013 | 65 | 0.110 |
Why?
|
| Barrett Esophagus | 1 | 2013 | 57 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2013 | 220 | 0.110 |
Why?
|
| Phenotype | 2 | 2013 | 946 | 0.100 |
Why?
|
| Bacteria | 1 | 2013 | 193 | 0.100 |
Why?
|
| Transcriptome | 1 | 2013 | 164 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 475 | 0.090 |
Why?
|
| Cell Line, Tumor | 3 | 2017 | 1851 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1070 | 0.070 |
Why?
|
| Cell Survival | 2 | 2017 | 901 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2016 | 431 | 0.050 |
Why?
|
| Humans | 9 | 2021 | 68549 | 0.050 |
Why?
|
| Karyopherins | 1 | 2021 | 11 | 0.050 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2021 | 55 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2021 | 28 | 0.050 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 57 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 138 | 0.050 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 91 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2021 | 90 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2021 | 238 | 0.050 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 17 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 369 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 852 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2019 | 41 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 546 | 0.040 |
Why?
|
| Protein Transport | 1 | 2019 | 280 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 186 | 0.040 |
Why?
|
| Mice | 2 | 2021 | 8474 | 0.040 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2017 | 6 | 0.040 |
Why?
|
| K562 Cells | 1 | 2017 | 44 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2021 | 508 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2017 | 54 | 0.040 |
Why?
|
| Prognosis | 1 | 2021 | 2093 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 500 | 0.030 |
Why?
|
| Histones | 1 | 2016 | 111 | 0.030 |
Why?
|
| Ceramides | 1 | 2019 | 578 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 337 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 261 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 1213 | 0.030 |
Why?
|
| Oxygen | 1 | 2017 | 386 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 333 | 0.030 |
Why?
|
| Drug Stability | 1 | 2013 | 71 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 2013 | 54 | 0.030 |
Why?
|
| Pacific Ocean | 1 | 2013 | 10 | 0.030 |
Why?
|
| Metagenomics | 1 | 2013 | 11 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2013 | 20 | 0.030 |
Why?
|
| Micelles | 1 | 2013 | 43 | 0.030 |
Why?
|
| Nanomedicine | 1 | 2013 | 19 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2013 | 93 | 0.030 |
Why?
|
| DNA, Mitochondrial | 1 | 2013 | 84 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2013 | 260 | 0.030 |
Why?
|
| Animals | 2 | 2021 | 20880 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2791 | 0.030 |
Why?
|
| Nanotechnology | 1 | 2013 | 109 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2013 | 149 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 346 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 2077 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 100 | 0.030 |
Why?
|
| Cell Respiration | 1 | 2012 | 47 | 0.030 |
Why?
|
| Microscopy | 1 | 2012 | 64 | 0.030 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 236 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 498 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2012 | 189 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2012 | 46 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 521 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 1752 | 0.020 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 778 | 0.020 |
Why?
|
| Male | 2 | 2021 | 37283 | 0.020 |
Why?
|
| Female | 2 | 2021 | 38021 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 1533 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 21119 | 0.010 |
Why?
|